Objectives
After participating in this educational activity, attendees should be able to:
1|Discuss various conceptual frameworks of combination therapy
2|Describe current evidence for advanced combination therapy in IBD
3|Outline the future of advanced combination therapy
4|Apply recommendations for current practice
Presenter(s):
Marla Dubinsky, MD
Professor of Pediatric and Medicine
Chief Division Pediatric GI and Nutrition
Co-Director Susan and Leonard Feinstein IBD Center
Director, Marie and Barry Lipman IBD Preconception and Pregnancy Planning Clinic
Icahn School of Medicine Mount Sinai, New York
Co-Founder & CEO, Trellus Health
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
---|---|---|---|
Marla Dubinsky, MD | Speaker | Consultant: Abiva, Abbvie, Alimentiv, Amgen, AstraZeneca | Real world studies on dual therapy will be discussed and trials |
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)